|
ZNF326 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.74669999999777E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.081500E-03 |
| Normal-vs-Stage2 |
1.151660E-02 |
| Normal-vs-Stage3 |
2.2540999999987E-05 |
| Normal-vs-Stage4 |
4.77930000020166E-08 |
| Stage1-vs-Stage2 |
4.444800E-01 |
| Stage1-vs-Stage3 |
1.687810E-02 |
| Stage1-vs-Stage4 |
1.786230E-04 |
| Stage2-vs-Stage3 |
4.561200E-01 |
| Stage2-vs-Stage4 |
1.358640E-01 |
| Stage3-vs-Stage4 |
2.461600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.21230000000605E-05 |
| Normal-vs-AfricanAmerican |
1.337030E-03 |
| Normal-vs-Asian |
4.198400E-01 |
| Caucasian-vs-AfricanAmerican |
8.883000E-01 |
| Caucasian-vs-Asian |
2.476100E-02 |
| AfricanAmerican-vs-Asian |
2.520000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.54370000002591E-06 |
| Normal-vs-Female |
5.796200E-03 |
| Male-vs-Female |
1.633780E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.289900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.040700E-03 |
| Normal-vs-Age(61-80Yrs) |
4.9950999999604E-06 |
| Normal-vs-Age(81-100Yrs) |
1.999960E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.368200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.296400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.072400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.259400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.465600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.170600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.629800E-01 |
| Normal-vs-Grade 2 |
4.643600E-02 |
| Normal-vs-Grade 3 |
2.34960000344842E-08 |
| Normal-vs-Grade 4 |
6.35109964619573E-10 |
| Grade 1-vs-Grade 2 |
7.320200E-02 |
| Grade 1-vs-Grade 3 |
7.044700E-04 |
| Grade 1-vs-Grade 4 |
1.69526000000086E-05 |
| Grade 2-vs-Grade 3 |
5.76989999999666E-05 |
| Grade 2-vs-Grade 4 |
5.73689999949778E-08 |
| Grade 3-vs-Grade 4 |
1.666380E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.407840E-01 |
| Normal-vs-ccB subtype |
4.09540000023689E-07 |
| ccA subtype-vs-ccB subtype |
2.22469999999753E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.802900E-04 |
| Normal-vs-N1 |
1.385190E-04 |
| N0-vs-N1 |
6.675600E-02 |
|
|
